<DOC>
	<DOCNO>NCT01336140</DOCNO>
	<brief_summary>The routine administration 75 mg intravenous aminophylline patient severe chronic kidney disease undergo nuclear stress test regadenoson ( Lexiscan® ) reduce eliminate incidence diarrhea side effect relate regadenoson .</brief_summary>
	<brief_title>Attenuation Side Effect Profile Regadenoson : Study With Aminophylline Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging</brief_title>
	<detailed_description>Approximately 300 patient severe chronic kidney disease refer nuclear stress test heart regadenoson ( Lexiscan® ) recruit participate study . Following regadenoson ( administer part stress routine test protocol ) participant receive either aminophylline ( 75 mg - intravenously ) match inactive placebo ( sterile salt water ) injection . Participants survey gastrointestinal symptom side effect relate regadenoson . The frequency severity side effect compare two study group ( aminophylline vs. placebo ) .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Regadenoson</mesh_term>
	<mesh_term>Aminophylline</mesh_term>
	<criteria>Adult patient refer undergo clinicallyindicated regadenosonstress myocardial perfusion image Rush University Medical Center Stage IV V chronic kidney disease ( GFR &lt; 30 , hemodialysis , and/or peritoneal dialysis ) . Patient refusal participate Known allergic reaction aminophylline . Preexisting headache acute/subacute GI illness symptom diarrhea , abdominal discomfort , nausea vomit . Any contraindication aminophylline : hypotension , unstable cardiac arrhythmia acute coronary symptom . Uncontrolled seizure disorder define 2 seizure episode past 12 month seizure past week . Pregnant breastfeed woman . Patients receive antiplatelet agent dipyridamole ( Persantine® Aggrenox® ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>regadenoson</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>renal failure</keyword>
	<keyword>lexiscan</keyword>
	<keyword>aminophylline</keyword>
	<keyword>SPECT</keyword>
	<keyword>Myocardial Perfusion Imaging</keyword>
	<keyword>pharmacologic stress test</keyword>
	<keyword>Patients stage IV V chronic kidney disease assess nuclear stress test heart use stress agent regadenoson ( Lexiscan ® )</keyword>
</DOC>